Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: S-3/A, Date: 2013-12-16
Original SEC Filing: Click here

---

Webplus: SKBI/20131216/S-3.A/1/000.htm SEC Original: v362774_s3a.htm
ORM Pre-effective Amendment No. 1 to F REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933ystar Bio-Pharmaceuticalmpany Nevada 2834 33-0901534 (State or other jurisdiction (Primary Standard Industrial (I.R.S. Employer oforporation or organization)de Number) Identification Number) 4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District Xian, Shaanxi Province, P.R. China

---

---

Webplus: SKBI/20131216/S-3.A/2_EX-5.1/000.htm SEC Original: v362774_ex5-1.htm
Schiff Hardin Letterhead [ December 16, 2013 Board of Directorsystar Bio-Pharmaceuticalmpany 4/F Building B, Chuangye Square, No. 48 Keji Road, Gaoxin District, Xian, Shaanxi Province, P.R. China Re Registration Statement on Form S-3 Ladies and Gentlemen: Based on the foregoing and subject to the qualifications set forth below, we are of the opinion that, when

---

---

Webplus: SKBI/20131216/S-3.A/3_EX-5.2/000.htm SEC Original: v362774_ex5-2.htm
[Emmel & Klegerman PC Letterhead] December 16, 2013ystar Bio-Pharmaceuticalmpany 4/F, Building B, Chuangye Square, No. 48 Keji Rd Gaoxin District, Xian, Shaanxi Province, P.R. China Ladies and Gentlemen:ystar Bio-Pharmaceuticalmpany December 16, 2013 Page 2 Innnection with this opinion letter, we have examined and relied uponpies of the following documents, together with such other documents we

---

Company Information:

Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: S-3/A, Date: 2013-12-16CIK: 0001076939, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
RM 10601, JIEZUO PLAZA, NO. 4, FENGHUI ROAD SOUTH, GAOXIN DISTRICT
XIAN PROVINCE